And we also recently entered into a new license with Incyte Corporation. We're looking to finish the year ... Phase 1/2 trial ...

esmo group (esmo), a leading global full-service systems integrator, developer, and supplier of innovative and advanced automation solutions, is proud to announce the launch of its latest product—the ...

Now, new data from the POD1UM-303 study reported at ESMO suggests the company could resurrect the SCAC indication and move Zynyz into the first-line setting to boot. Given in combination with ...

Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today highlighted pipeline ...

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today reported financial results for the third quarter ended September 30, 2024, and provided recent business ...

The results of the GALAXIES Lung-02 study reported at the ESMO congress in Barcelona showed that the drug – added to GSK's PD-1 inhibitor Jemperli (dostarlimab) – achieved a higher objective ...

Liberty Media Corp. Series C Liberty Formula One-0.55% $24.59B Liberty Media Corp. Series A Liberty Formula One-0.44% $24.59B Liberty Broadband Corp. Cl A-1.04% $14.07B Liberty Broadband Corp. Cl ...

On Nov. 7, Insulet reported better-than-expected third-quarter financial results. “We continue to achieve significant milestones and robust revenue growth,” said Jim Hollingshead, President and Chief ...

at 07:10 Bruker Corporation to Present at Upcoming Investor Conferences Bruker Corporation announced today that Gerald Herman, Executive Vice President & CFO will present on behalf of the Company at ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...